Ptc Therapeutics (PTCT) Amortizatization of Intangibles (2014 - 2026)

Ptc Therapeutics' (PTCT) quarterly Amortizatization of Intangibles came in at $4.1 million in Q1 2026, up 77.86% year-on-year from $2.3 million in Q1 2025, and down 18.53% quarter-over-quarter from $5.0 million in Q4 2025.

Ptc Therapeutics (PTCT) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends

Ptc Therapeutics' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $4.1 million for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles rose 77.86% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $19.8 million, a 77.86% increase from a year earlier, with the FY2025 full-year figure at $18.0 million, up 43.84% from the prior year.
  • Amortizatization of Intangibles retreated to $4.1 million in Q1 2026 per PTCT's latest filing, from $5.0 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $6.1 million in Q3 2025 and bottomed at -$887000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $2.3 million (2025), against an average of $2.1 million.
  • Across the five-year window, Amortizatization of Intangibles jumped 295300.0% in 2024 and slumped 37.44% in 2025, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $79000.0 in 2022, then jumped by 2572.15% to $2.1 million in 2023, then advanced by 22.31% to $2.6 million in 2024, then jumped by 95.58% to $5.0 million in 2025, then decreased by 18.53% to $4.1 million in 2026.
  • Per Business Quant, the three latest PTCT Amortizatization of Intangibles figures stand at $4.1 million (Q1 2026), $5.0 million (Q4 2025), and $6.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Ptc Therapeutics 6.27 Bn 4.38 Bn 244.52 Mn 4.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.11 Mn
Mar 31, 2026 4.11 Mn
Dec 31, 2025 5.05 Mn
Dec 31, 2025 5.05 Mn
Sep 30, 2025 6.10 Mn
Sep 30, 2025 6.10 Mn
Jun 30, 2025 4.56 Mn
Jun 30, 2025 4.56 Mn
Mar 31, 2025 2.31 Mn
Mar 31, 2025 2.31 Mn
Dec 31, 2024 2.58 Mn
Dec 31, 2024 2.58 Mn
Sep 30, 2024 2.95 Mn
Sep 30, 2024 2.95 Mn
Jun 30, 2024 3.30 Mn
Jun 30, 2024 3.30 Mn
Mar 31, 2024 3.70 Mn
Mar 31, 2024 3.70 Mn
Dec 31, 2023 2.11 Mn
Dec 31, 2023 2.11 Mn